AstraZeneca PLC is among the top cancer stocks favored by hedge funds. Cancer remains a leading global cause of death, prompting innovative strategies like immunotherapy and mRNA treatments. Companies are investing in radiopharmaceuticals for targeted cancer treatment, potentially generating billions in revenue.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing